Radiation Oncology/Therapy: Page 198

Polymers could ease brachytherapy seed delivery
By Cynthia E. Keen
Surgical implantation and removal of radioactive seeds is required for brachytherapy cancer treatment. Use of polymers may eliminate the need for this invasive procedure when treating solid tumors, according to data published in the November 15 issue of Cancer Research.
November 15, 2012
New 'LUNG-RADS' scheme sorts out screening results
By Eric Barnes
Thursday, November 29 | 11:40 a.m.-11:50 a.m. | SSQ10-08 | Room S403AA new "LUNG-RADS" system for lung cancer screening with CT aims to standardize the reporting of findings, both pulmonary and extrapulmonary, according to researchers from the Lahey Institute in Burlington, MA, who developed the system late last year.
November 15, 2012
Lesion-tracking tool reduces errors and increases efficiency
By Cynthia E. Keen
Tuesday, November 27 | 3:20 p.m.-3:30 p.m. | SSJ13-03 | Room S402ABAn annotation and image markup lesion-tracking tool measuring changes in size, or lack thereof, in tumors shown on diagnostic imaging exams of cancer patients is producing significant improvements in oncologic lesion measurement efficiency, as well as reductions in documentation errors, at the University of Chicago.
November 15, 2012
Lesion-tracking tool boosts efficiency in RECIST assessments
By Erik L. Ridley
Monday, November 26 | 11:10 a.m.-11:20 a.m. | SSC08-05 | Room S402ABA study team will describe how an automated lesion-tracking tool improves radiologist efficiency for quantitative assessment of cancer response on CT studies.
November 15, 2012
DCE- and DWI-MRI show neoadjuvant chemotherapy results in breast cancer
By Wayne Forrest
Tuesday, November 27 | 11:10 a.m.-11:20 a.m. | SSG01-05 | Arie Crown TheaterBoth dynamic contrast-enhanced (DCE) and diffusion-weighted (DWI) MRI can accurately reflect response to neoadjuvant chemotherapy among breast cancer patients during treatment with minimum apparent diffusion coefficient (ADC) as the most predictive marker of pathologic response, according to a study to be presented on Tuesday.
November 14, 2012
US, MRI tumor measurements can predict residual disease
By Kate Madden Yee
Sunday, November 25 | 12:30 p.m.-1:00 p.m. | LL-BRS-SU5A | Lakeside Learning CenterHow best can doctors assess residual disease in inflammatory breast cancer patients who have undergone neoadjuvant chemotherapy? Find out in this Sunday poster presentation.
November 13, 2012
FDG-PET/CT works for primary breast cancer staging
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABFDG-PET/CT may be used as primary staging modality in patients with primary breast cancer, according to this Sunday morning presentation to be given by German researchers.
November 13, 2012
Semiautomated CT lesion analysis saves time
By Erik L. Ridley
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG18-08 | Room S104AA team from the U.S. National Institutes of Health (NIH) has found that a semiautomated lesion management application was faster and more consistent than manual observers in assessing cancer therapy response.
November 11, 2012
Method segments functional, anatomic areas on PET/MRI
By Erik L. Ridley
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG09-08 | Room S402ABA team from the U.S. National Institutes of Health will present a segmentation method that can simultaneously and automatically delineate regions of radiotracer uptake and corresponding anatomical structures on PET/MRI scans.
November 11, 2012
Semiautomated assessment tool evaluates tumor burden
By Erik L. Ridley
Tuesday, November 27 | 11:30 a.m.-11:40 a.m. | SSG09-07 | Room S402ABResearchers from the U.S. National Institutes of Health will present the results of a semiautomated metastatic lesion measurement tool for providing tumor assessment in melanoma patients.
November 11, 2012
Computer reasoning may improve cancer treatment assessment
By Erik L. Ridley
Tuesday, November 27 | 11:10 a.m.-11:20 a.m. | SSG09-05 | Room S402ABIn this Tuesday morning presentation, Stanford University researchers will discuss their approach to automate and reduce variation in imaging assessment of treatment response.
November 11, 2012
Lesion tracking tool boosts efficiency in RECIST assessments
By Erik L. Ridley
Monday, November 26 | 11:10 a.m.-11:20 a.m. | SSC08-05 | Room S402ABA study team will describe how an automated lesion tracking tool improves radiologist efficiency for quantitative assessment of cancer response on CT studies.
November 11, 2012
Previous Page
Page 198 of 464
Next Page